Jane and Aatos Erkko Foundation Grants €1.7 million for Riitta Lahesmaa
Jane and Aatos Erkko Foundation has awarded 1.7 million euros for T-cell research that is led by academy professor Riitta Lahesmaa.
T-cells are critical in regulating the human immune system. Functioning appropriately, they protect us from infection, autoimmune disease, and cancer. Professor Lahesmaa’s group focuses on identifying and understanding new regulators of human T cell differentiation and function.
This research has significant breakthrough potential in understandin how cancer and inflammatory and autoimmune diseases develop.
Jane and Aatos Erkko Foundation supports high-level, international scientific research as well as arts and culture.
Recent Posts
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- Call is now open for BioCity Turku research programs 2027-2031Life science researchers on the Turku campus are invited to submit proposals for new BioCity Read moreJune 10, 2026
- Early-career researchers invited to BioCity Pre-Symposium on 26 August. Registration is now open!Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026. Registration is now open!This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026